Credit Suisse Ag Veru Inc. Transaction History

Credit Suisse Ag

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$1.16 - $6.41 $4,309 - $23,813	3,715 Added 4.79%	81,260 $94,000
Q4 2022 Feb 13, 2023	BUY	$4.78 - $15.01 $89,668 - $281,572	18,759 Added 31.91%	77,545 $409,000
Q3 2022 Nov 10, 2022	BUY	$10.22 - $23.7 $68,647 - $159,192	6,717 Added 12.9%	58,786 $677,000
Q2 2022 Aug 12, 2022	BUY	$4.35 - $15.85 $24,090 - $87,777	5,538 Added 11.9%	52,069 $589,000
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $8,526 - $12,012	1,874 Added 4.2%	46,531 $225,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $48,610 - $80,301	8,253 Added 22.67%	44,657 $262,000
Q3 2021 Nov 12, 2021	BUY	$6.78 - $9.89 $51,168 - $74,639	7,547 Added 26.15%	36,404 $311,000
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $128,401 - $198,632	17,735 Added 159.46%	28,857 $232,000
Q1 2021 May 14, 2021	SELL	$8.05 - $20.78 $28,231 - $72,875	-3,507 Reduced 23.97%	11,122 $120,000
Q4 2020 Feb 12, 2021	BUY	$2.36 - $9.99 $34,524 - $146,143	14,629 New	14,629 $126,000
Q1 2020 May 13, 2020	SELL	$2.58 - $4.58 $288,972 - $512,982	-112,005 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.86 - $3.35 $208,329 - $375,216	112,005 New	112,005 $375,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.